A phase II trial of ivonescimab for previously treated thymic carcinoma: UCLA L-11.
A phase II trial of ivonescimab for previously treated thymic carcinoma: UCLA L-11. is a paper indexed in ScholarIQ from OpenAlex.
How many citations does A phase II trial of ivonescimab for previously treated thymic carcinoma: UCLA L-11. have?
A phase II trial of ivonescimab for previously treated thymic carcinoma: UCLA L-11. has 0 citations in the OpenAlex counts ScholarIQ stores.
When was A phase II trial of ivonescimab for previously treated thymic carcinoma: UCLA L-11. published?
A phase II trial of ivonescimab for previously treated thymic carcinoma: UCLA L-11. has 2026 year in the ScholarIQ index.
What is the open-access status of A phase II trial of ivonescimab for previously treated thymic carcinoma: UCLA L-11.?
A phase II trial of ivonescimab for previously treated thymic carcinoma: UCLA L-11. has bronze oa status in the ScholarIQ index.
What is the DOI of A phase II trial of ivonescimab for previously treated thymic carcinoma: UCLA L-11.?
The DOI for A phase II trial of ivonescimab for previously treated thymic carcinoma: UCLA L-11. is on the source record.
What is the OpenAlex record for A phase II trial of ivonescimab for previously treated thymic carcinoma: UCLA L-11.?
The OpenAlex for A phase II trial of ivonescimab for previously treated thymic carcinoma: UCLA L-11. is on the source record.